Welcome to our dedicated page for ACCENDRA HEALTH INC/VA/ SEC filings (Ticker: OMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ACCENDRA HEALTH INC/VA/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ACCENDRA HEALTH INC/VA/'s regulatory disclosures and financial reporting.
Owens & Minor reported consolidated results showing continuing operations revenue rose to $681.9 million for the quarter and $1.356 billion for the six months, up from $660.4 million and $1.298 billion a year earlier. Continuing operations produced an operating loss of $39.7 million for the quarter and a pre-tax loss of $84.9 million, after recording an $80 million transaction breakage fee and acquisition-related charges.
The company classified its Products & Healthcare Services (P&HS) segment as discontinued operations and held-for-sale, recognizing a $106.4 million goodwill impairment and a $649.1 million loss on classification, contributing to a quarterly net loss of $869.1 million and basic loss per share of $11.30. Total assets were $4.15 billion with total liabilities of $4.44 billion, resulting in a deficit equity of $281.0 million at June 30, 2025. The divestiture process is described as in the final stages.
Owens & Minor, Inc. announced that it issued a press release reporting its financial results for the second quarter and for the six months ended June 30, 2025, and posted an earnings presentation on its Investor Relations website. The company furnished the press release as Exhibit 99.1, the earnings presentation as Exhibit 99.2, and included an Inline XBRL cover page as Exhibit 104. The 8-K states these materials are furnished under Item 2.02 and Item 7.01 and explicitly notes they are not "filed" for purposes of Section 18 of the Exchange Act. The numeric results and supporting slides are contained in the attached exhibits and on the company website rather than in the body of this filing.